Onderzoeksgrade Rovelizumab

Bispecific, Hu23F2G,23F2G, CAS:339086-79-2

Mammalian Cells

ComplementreceptorC3subunitbeta, CellsurfaceadhesionglycoproteinsLFA-1/CR3/p150,95subunitbeta, Integrinbeta-2, MFI7, CD18, ITGB2, CD11A, Leukocytefunction-associatedmolecule1alphachain, LeukocyteadhesionglycoproteinLFA-1alphachain, LFA-1A, CD11antigen-likefamilymemberA, CD11a, ITGAL, Integrinalpha-L, CR-3alphachain, CellsurfaceglycoproteinMAC-1subunitalpha, LeukocyteadhesionreceptorMO1, ITGAM, CD11b, CD11antigen-likefamilymemberB, Integrinalpha-M, CR3A, CD11B, Neutrophiladherencereceptor

ELISA, Bioactivity: FACS, Functional assay, Research in vivo

Protein A/G purified from cell culture supernatant.

1mg/ml

Please contact with the lab for this information.

>95% as determined by SDS-PAGE.

Liquid

0.01M PBS, pH7.4.

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at4°C short term (1-2weeks) . Store at-20°C 12 months. Store at -165°C long term.

For research use only. Not suitable for clinical or therapeutic use.

0.01M PBS, pH7.4.

Human

IgG4-nd